Castle Biosciences Inc
NASDAQ:CSTL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
17.4
34.67
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Castle Biosciences Inc
Wall Street
Price Targets
CSTL Price Targets Summary
Castle Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
CSTL
is 42.39 USD
with a low forecast of 36.36 USD and a high forecast of 52.5 USD.
CSTL Last Price Targets
Castle Biosciences Inc
The latest public price target was made on Nov 5, 2024 by
Catherine Schulte
from
Robert W. Baird
,
who expects
CSTL
stock to
rise by 31%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Catherine Schulte
Robert W. Baird
|
39
USD
Upside 31% |
2 weeks ago
Nov 5, 2024
|
Castle Biosciences (CSTL) PT Raised to $39 at Baird
StreetInsider
|
Paul Knight
KeyBanc
|
36
USD
Upside 21% |
2 weeks ago
Nov 5, 2024
|
Castle Biosciences (CSTL) PT Raised to $36 at KeyBanc
StreetInsider
|
|
Sung Ji Nam
BTIG
|
45
USD
Upside 51% |
2 weeks ago
Nov 5, 2024
|
Castle Biosciences (CSTL) PT Raised to $45 at BTIG
StreetInsider
|
Kyle Mikson
Canaccord Genuity
|
42
USD
Upside 41% |
3 weeks ago
Oct 29, 2024
|
Castle Biosciences (CSTL) PT Raised to $42 at Canaccord Genuity
StreetInsider
|
|
Sung Ji Nam
BTIG
|
40
USD
Upside 34% |
1 month ago
Oct 14, 2024
|
Castle Biosciences (CSTL) PT Raised to $40 at BTIG
StreetInsider
|
|
Sung Ji Nam
BTIG
|
35
USD
Upside 17% |
3 months ago
Aug 6, 2024
|
Castle Biosciences (CSTL) PT Raised to $35 at BTIG
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CSTL's stock price target?
Price Target
42.39
USD
According to Wall Street analysts, the average 1-year price target for
CSTL
is 42.39 USD
with a low forecast of 36.36 USD and a high forecast of 52.5 USD.
What is Castle Biosciences Inc's Revenue forecast?
Projected CAGR
12%
For the last 5 years the
compound annual growth rate for
Castle Biosciences Inc's revenue is
57%.
The projected
CAGR
for the next 3 years is
12%.
You don't have any saved screeners yet
